Can tirzepatide cause depression? What the data shows

Can tirzepatide cause depression? Can Mounjaro cause depression? What about Zepbound? These are common questions that deserve a straight answer.

The US Food and Drug Administration (FDA) hasn’t found a clear link between GLP-1 receptor agonists and suicidal ideation. That said, the FDA notes it cannot fully rule out that a small risk may exist, and is still looking into it.

This article breaks down what the research shows and what to do if you notice mood changes on tirzepatide.

Tirzepatide hasn’t been shown to cause depression. No clear causal link exists between tirzepatide and depression based on current evidence, but the FDA continues to collect safety data.

As of March 2026, the FDA reviewed available data and found no increased risk of suicidal thoughts or behaviors in people taking GLP-1s. As such, the FDA has asked manufacturers to remove warnings about suicidal ideation and behavior from the medication labeling. 

These warnings were originally included as a precaution, partly based on concerns seen with older weight loss medications. However, after a comprehensive review, the FDA determined that this risk does not appear to be linked to GLP-1 medications.

A 2024 study reviewed over 31,000 adverse event reports for three GLP-1 medications: semaglutide, liraglutide, and tirzepatide. Psychiatric adverse events made up just 1.18% of all reports.

Mood changes can happen for some people on tirzepatide. But what's driving them isn't always clear and may vary from person to person. The sections below walk through some of the possible reasons.

Get started

Tirzepatide may improve mood for some people. Some case reports suggest this may be especially relevant for people who already have depression or anxiety.

Two psychiatrists published a 2025 report documenting significant improvement in depression and anxiety symptoms in two patients who started tirzepatide:

• The first patient was a 36-year-old with major depressive disorder, generalized anxiety disorder, and binge-eating disorder. Their mood worsened each time tirzepatide was tapered or stopped. Their mood improved again each time the dose was restarted or increased. Other psychiatric medications they were on didn’t change during this period. They also felt the mood benefit was unrelated to the weight loss.

• The second patient was a 44-year-old with major depressive disorder, ADHD, anxiety, and obesity. They saw rapid mood improvement within days of increasing the dose to 5 mg, and further improvement at 7.5 mg. This happened before significant weight loss had occurred. When her dose was later lowered, she reported her mood wasn’t as good, though still positive.

In both cases, the mood benefit appeared before meaningful weight loss. This suggests tirzepatide may act directly on the brain rather than improving mood simply through weight change.

Researchers have proposed several possible reasons, including reduced inflammation and effects in the central nervous system.

However, it’s important to remember that these are case reports, not clinical trials. Firm conclusions can’t be drawn from two cases alone. But they add to a growing body of evidence suggesting GLP-1 receptor agonists may have real mental health benefits worth studying further.

When it comes to Zepbound or Mounjaro mental health side effects, some people do notice negative mood changes. In most cases, these mood shifts are not due to the medication itself but rather a result of the changes that can come with the drug, such as:  

• Food and coping: Tirzepatide reduces your appetite. For some people, food can be a source of comfort or emotional relief. When that mechanism is removed, feelings of flatness, emptiness, or low mood can emerge, not because the drug is causing depression, but because a familiar coping tool is gone.

• Nutritional deficiencies: Eating significantly less can lead to lower intake of key nutrients linked to mood regulation, including vitamin B12, vitamin D, magnesium, and omega-3 fatty acids. A study found that deficiencies in these and other nutrients are associated with a higher prevalence of depressive symptoms. If appetite suppression is leading to reduced dietary variety, nutritional gaps may be a contributing factor.

• Blood sugar fluctuations: Tirzepatide affects glucose regulation, and blood sugar shifts can influence mood. When people feel hungry or experience drops in glucose, their mood tends to dip too. As the body adjusts to tirzepatide's effects on glucose and appetite, some people may notice greater mood variability in the early weeks.

• Rapid lifestyle change: Starting a weight loss medication can bring significant psychological shifts. There might be new habits, changing social dynamics around food, and adjusting to a different body. These transitions, while often positive overall, can stir up complex emotions.

None of this means you should dismiss mood changes: those feelings are real and worth taking seriously. If they persist or feel overwhelming, that's a signal to speak with a healthcare provider.

People on GLP-1 receptor agonists seem less likely to develop suicidal ideation than those on non-GLP-1 alternatives, not more.

A large study using electronic health records from over 100 million US patients found that semaglutide was associated with a significantly lower risk of both first-time and recurring suicidal ideation compared to non-GLP-1 anti-obesity and anti-diabetes medications.

This association held across different ages, sexes, and ethnicities, and remained consistent in follow-ups of up to three years. 

The study focused on semaglutide, not tirzepatide specifically. But the findings fit within a broader pattern suggesting that GLP-1 receptor agonists aren’t a psychiatric risk, and may even carry mental health benefits for some people.

The FDA has also recently reviewed a wide range of data to understand whether GLP-1 medications increase the risk of suicidality. Across 91 clinical trials (107,910 patients) and real-world data from over 2.2 million people, the FDA found no evidence that GLP-1 medications increase the risk of suicidal thoughts or behaviors.

It's worth knowing what to look out for, regardless of what's causing mood changes. Signs that may indicate depression and warrant a conversation with a healthcare provider include:

• Disturbed sleep

• Showing less interest in things

• A reduced sense of pleasure

• Feelings or thoughts of guilt or worthlessness

• Changes in energy levels or fatigue 

• Reduced concentration or attention span

• Depressed mood

• Suicidal thoughts

If any of these feel familiar and have been ongoing, reaching out to a healthcare provider is the right move, whether or not you're on tirzepatide.

If you have mood changes while on tirzepatide, don't stop taking it on your own without speaking to a healthcare provider first. Mood changes don't automatically mean tirzepatide is the cause, and stopping the medication abruptly may not be necessary or helpful.

Instead, bring it up with your provider. Describe when the mood changes started, how long they've been present, what you’re feeling and thinking, and whether they've changed with dose adjustments.

A healthcare provider can help figure out whether the medication, lifestyle changes, nutritional factors, or something unrelated is most likely responsible, and what to do next.

You can reach your Ro provider 24 hours a day if you need to start that conversation.

Check your coverage for FDA-approved GLP-1s—for free

Check for free

Can tirzepatide cause depression? Based on current evidence, not necessarily. A thorough review by the FDA found no increased risk of suicidal ideation with the use of tirzepatide or similar medications.

Here's what the research does show:

• Psychiatric adverse events are rare with tirzepatide. In a study of over 31,000 adverse event reports for three GLP-1 medications, psychiatric events comprised only 1.18% of the total. 

• Tirzepatide may improve mood for some people. Two documented cases showed significant improvement in depression and anxiety that happened before weight loss.

• Mood changes, if they happen, are more likely an indirect effect of the medication. Loss of food as a coping tool, nutritional shifts, blood sugar fluctuations, and the emotions involved with a lifestyle change can all affect how you feel.

If you notice persistent mood changes while on tirzepatide, or need help with Mounjaro or Zepbound, depression, or side effects, speak to your healthcare provider. They can help you figure out what's actually going on.